
STATINS reduce illness and mortality from those at risk of cardiovascular disease. Now medical professionals are intrigued whether the cholesterol-lowering drug will benefit patients suffering from long Covid - and so a three-year trial is set to begin.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.